trending Market Intelligence /marketintelligence/en/news-insights/trending/CL3MmFIdWlZ4AUr7XbLgDw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Rocket Pharmaceuticals to raise almost $85M from common stock offering

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Rocket Pharmaceuticals to raise almost $85M from common stock offering

Rocket Pharmaceuticals Inc. priced a public offering of its common stock to raise almost $85 million in gross proceeds.

The New York-based biotechnology company is offering 3,820,000 shares at $22.25 apiece. Underwriters will also receive an option to buy up to an additional 573,000 shares.

The offering is scheduled to close Dec. 13.

J.P. Morgan, Cowen and Evercore ISI are acting as joint book-running managers for the offering, while LifeSci Capital LLC is acting as co-manager.

Rocket intends to use the net proceeds to develop its gene therapies for rare diseases, aid the expansion of in-house manufacturing capabilities and for general corporate purposes.

In April, the company raised $90.6 million for similar purposes in an underwritten offering of 5,175,000 common shares at $17.50 apiece.